Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication In Vitro. Jorquera PA, Mathew C, Pickens J, Williams C, et al. J Virol 2019;93.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jorquera PA, Mathew C, Pickens J, Williams C, et al. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication In Vitro. J Virol 2019;93.
PMID: 30541831